| Home | E-Submission | Sitemap | Contact Us |  
J Korean Cancer Assoc > Volume 26(2); 1994 > Article
Journal of the Korean Cancer Association 1994;26(2): 219-231.
SNU 간암세포주들의 다중약제내성 1 유전자 발현과 항암제에 대한 감수성 검사
홍인규, 이성규, 이현주, 임경화, 김헌식, 박재갑
MDR1 Gene Expression and Chemosensitivity to Anticancer Drugs in SNU Hepatocellular Carcinoma Cell Lines
In Gyu Hong, Sung Gyu Lee, Hyun Ju Lee, Gyung Hwa Him, Hun Sik Kim, Jae Gahb Park
Using recently established 8 SNU human hepatocellular carcinoma cell lines and Hep 3B cell line, we performed in vitro chemosensitivity test using semiautomated tetrazolium-based colorimetric(MTT) assay. We also measured the MDRl gene expression of these cell lines by measuring MDR1 RNA level using slot blot analysis. IC values(concentration of chemotherapeutic agent which produces 50% growth inhibition of tested cells) were in the range of 1.92~5000 ↑ ug/ml for 5-fluorouracil, 0.24~32.00 ug/ml for doxorubicin, 0.16-10.29 pg/ml for mitomycin-c, 2.00~16.56 ug/ml for cisplatin, 1.15-182.32 ug/ml for etoposide, and 0.002 ↓L -24 ↑ug/ml for vincristine. Assay area under the curve(A-AUC) at IC: values showed that only A-AUC of VP-16 was in a clinically achievable range for only one of the 9 cell lines. All other drugs were out of the range of clinically achievabie AUC. Three cell lines(SNU-354, SNU-368, SNU-449) were MDR-positive. When these 3 cell lines were compared to MDR-negative cell lines, IC value for doxorubicin was significantly higher (P<0.05), suggesting that high expression of MDRl gene is responsible for doxorubicin resistance in hepatocellular carcinoma cell lines.
Key words: Hepatocellular carcinoma cell lines, In Vitro chemosensitivity, MDRl gene expression
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI